2017 Sec 1 Green Book

Oral Propranolol in Infantile Hemangioma

treatment of periocular infantile heman- giomas with oral propranolol. J AAPOS 2010;14:251-6. 33. Snir M, Reich U, Siegel R, et al. Re- fractive and structural changes in infan- tile periocular capillary haemangioma treated with propranolol. Eye (Lond) 2011; 25:1627-34. 34. Fuchsmann C, Quintal MC, Giguere C, et al. Propranolol as first-line treatment

of head and neck hemangiomas. Arch Otolaryngol Head Neck Surg 2011;137: 471-8. 35. Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, et al. Efficacy of proprano- lol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pe- diatr 2010;157:340-2. 36. Metry D, Frieden IJ, Hess C, et al. Pro- pranolol use in PHACE syndrome with

cervical and intracranial arterial anoma- lies: collective experience in 32 infants. Pediatr Dermatol 2013;30:71-89. 37. Phillips RJ, Penington AJ, Bekhor PS, Crock CM. Use of propranolol for treat- ment of infantile haemangiomas in an outpatient setting. J Paediatr Child Health 2012;48:902-6. Copyright © 2015 Massachusetts Medical Society.

n engl j med 372;8  nejm.org february 19 , 2015

209